We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$3.03B
AUM Growth
+$310M
Cap. Flow
+$127M
Cap. Flow %
4.19%
Top 10 Hldgs %
31.87%
Holding
971
New
101
Increased
446
Reduced
291
Closed
89

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Technology 13.41%
3 Financials 6.98%
4 Industrials 5.88%
5 Consumer Discretionary 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLP icon
201
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
$2.25M 0.07%
28,955
+361
+1% +$28.2K
JBI icon
202
Janus International
JBI
$757M
$2.24M 0.07%
343,026
-2,596
-0.8% -$20.2K
AXS icon
203
AXIS Capital
AXS
$7.55B
$2.23M 0.07%
20,804
+465
+2% +$46.2K
BOXX icon
204
Alpha Architect 1-3 Month Box ETF
BOXX
$13.5B
$2.23M 0.07%
19,350
-2,742
-12% -$314K
ADSK icon
205
Autodesk
ADSK
$52.6B
$2.21M 0.07%
7,477
+316
+4% +$95.6K
DG icon
206
Dollar General
DG
$27.9B
$2.21M 0.07%
16,621
+7,621
+85% +$850K
LGLV icon
207
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.23B
$2.12M 0.07%
12,052
+134
+1% +$23.5K
EXEL icon
208
Exelixis
EXEL
$13.4B
$2.12M 0.07%
48,264
+14,405
+43% +$596K
PM icon
209
Philip Morris
PM
$295B
$2.08M 0.07%
12,945
-5,112
-28% -$792K
BIIB icon
210
Biogen
BIIB
$30.7B
$2.07M 0.07%
11,783
+158
+1% +$25.8K
ADT icon
211
ADT
ADT
$5.58B
$2.07M 0.07%
256,777
+5,192
+2% +$43.2K
HOOD icon
212
Robinhood
HOOD
$83.9B
$2.07M 0.07%
18,286
-7,570
-29% -$985K
TGT icon
213
Target
TGT
$68B
$2.06M 0.07%
21,068
+9,376
+80% +$864K
EXAS
214
DELISTED
Exact Sciences
EXAS
$2.03M 0.07%
20,034
+12,941
+182% +$1.04M
WST icon
215
West Pharmaceutical
WST
$24.9B
$2.02M 0.07%
7,346
+26
+0.4% +$7.11K
TER icon
216
Teradyne
TER
$59.3B
$2.01M 0.07%
10,401
+529
+5% +$90.8K
AMAT icon
217
Applied Materials
AMAT
$428B
$2.01M 0.07%
7,816
-56
-0.7% -$13.4K
ESTC icon
218
Elastic
ESTC
$7.81B
$2M 0.07%
26,488
+12,459
+89% +$1.02M
UTHR icon
219
United Therapeutics
UTHR
$23.1B
$2M 0.07%
4,101
+2,445
+148% +$1.14M
MAR icon
220
Marriott International
MAR
$92.3B
$2M 0.07%
6,436
-1,201
-16% -$343K
ZS icon
221
Zscaler
ZS
$27.3B
$1.99M 0.07%
8,834
-893
-9% -$252K
NOC icon
222
Northrop Grumman
NOC
$81.2B
$1.99M 0.07%
3,484
+43
+1% +$25K
A icon
223
Agilent Technologies
A
$41.2B
$1.96M 0.06%
14,413
+2
+0% +$287
SMLF icon
224
iShares US Small Cap Equity Factor ETF
SMLF
$4.3B
$1.96M 0.06%
26,113
+68
+0.3% +$5.07K
IT icon
225
Gartner
IT
$11.7B
$1.93M 0.06%
7,670
+1,725
+29% +$415K

Similar funds

Pallas Capital Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Pallas Capital Advisors held 971 positions worth $3.03B, up 11% from $2.72B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Pallas Capital Advisors deployed $127M of net new capital in Q4 2025, opening 101 new positions and adding to 446 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 600 Small Cap ETF: 85,665 shares worth $4.01M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $5.48M trimmed.

  • Pallas Capital Advisors's largest Q4 2025 buy was State Street SPDR Portfolio S&P 600 Small Cap ETF: 85,665 shares worth $4.01M.
  • Pallas Capital Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $19.4M increase.
  • Pallas Capital Advisors's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $5.48M.
  • Pallas Capital Advisors fully exited Molina Healthcare in Q4 2025, selling an estimated $2.38M.
  • Pallas Capital Advisors's ten largest holdings make up 32% of its $3.03B portfolio in Q4 2025.
  • Pallas Capital Advisors opened 101 new positions and closed 89 in Q4 2025.
  • Pallas Capital Advisors's portfolio value rose 11% quarter-over-quarter to $3.03B.

Based on Pallas Capital Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.